CEO & Chief Scientific Officer of Amphastar Pharmaceuticals Inc (30-Year Financial, Insider Trades) Jack Y. Zhang (insider trades) sold 41,869 shares of AMPH on 02/04/2021 at an average price of $18.69 a share. The total sale was $782,532.
Amphastar Pharmaceuticals Inc is a specialty pharmaceutical company engaged in developing, manufacturing, marketing and selling generic and proprietary injectable & inhalation products. Its products are used in hospitals or urgent care clinical settings. Amphastar Pharmaceuticals Inc has a market cap of $905.903 million; its shares were traded at around $19.070000 with a P/E ratio of 140.21 and P/S ratio of 2.74. GuruFocus has detected 1 severe warning sign with Amphastar Pharmaceuticals Inc. .
CEO Recent Trades:
- CEO & Chief Scientific Officer, 10% Owner Jack Y. Zhang sold 41,869 shares of AMPH stock on 02/04/2021 at the average price of $18.69. The price of the stock has increased by 2.03% since.
- CEO & Chief Scientific Officer, 10% Owner Jack Y. Zhang sold 37,931 shares of AMPH stock on 02/02/2021 at the average price of $18.43. The price of the stock has increased by 3.47% since.
CFO Recent Trades:
- CFO, SVP & Treasurer William J Peters sold 6,495 shares of AMPH stock on 01/19/2021 at the average price of $18.67. The price of the stock has increased by 2.14% since.
Directors and Officers Recent Trades:
- Director Floyd F. Petersen sold 639 shares of AMPH stock on 02/01/2021 at the average price of $18.26. The price of the stock has increased by 4.44% since.
For the complete insider trading history of AMPH, click here
.
